RNXT RenovoRx, Inc.
Healthcare$0.92+3.89%ClosedMarket Cap: $34.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.98
P/S
22.04
EV/EBITDA
-1.60
DCF Value
$0.92
FCF Yield
-34.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.7%
Operating Margin
-864.3%
Net Margin
-824.0%
ROE
-138.6%
ROA
-87.9%
ROIC
-106.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $563.0K | 85.1% | $-3.5M | $-3.5M | $— | — |
| Q4 null | $238.0K | 88.2% | $-3.5M | $-2.9M | $— | — |
| FY null | $1.1M | 70.9% | $-12.5M | $-11.2M | $— | — |
| Q3 null | $266.0K | 80.1% | $-3.2M | $-2.9M | $— | — |
| Q2 null | $422.0K | 64.0% | $-2.7M | $-2.9M | $— | — |
| Q1 null | $197.0K | 52.3% | $-3.1M | $-2.4M | $— | — |
| Q4 null | $43.0K | 100.0% | $-2.6M | $-2.9M | $— | — |
| FY null | $43.0K | 100.0% | $-11.0M | $-8.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.8M | $-2.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.0M | $-2.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.5M | $-1.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-1.8M | $-3.2M | $-0.15 | — |